Jefferies Remains a Buy on Brookdale Senior Living (BKD)
In a report released today, Brian Tanquilut from Jefferies maintained a Buy rating on Brookdale Senior Living, with a price target of $23.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Tanquilut is a 4-star analyst with an average return of 5.9% and a 52.75% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Chemed, HCA Healthcare, and Enhabit, Inc.
In addition to Jefferies, Brookdale Senior Living also received a Buy from RBC Capital’s Ben Hendrix in a report issued yesterday. However, today, TipRanks – Anthropic reiterated a Hold rating on Brookdale Senior Living (NYSE: BKD).
Based on Brookdale Senior Living’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $829.14 million and a GAAP net loss of $39.96 million. In comparison, last year the company earned a revenue of $746.98 million and had a GAAP net loss of $83.92 million
Read More on BKD:
Disclaimer & DisclosureReport an Issue
- Brookdale Senior Living price target raised to $19.50 from $18 at BofA
- Brookdale Senior Living Reports Strong 2025 Results, Refinances Debt
- Brookdale Senior Living reports Q4 EPS (17c) vs. (37c) last year
- Brookdale Senior Living still sees 2026 adjusted EBITDA $502M-$516M
- BKD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
